Jan 05, 2017 13:02 pm UTC| Business
CHANDLER, Ariz., Jan. 05, 2017 -- Microchip Technology Inc. (NASDAQ:MCHP), a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, today announced that Daimler AG plans to utilize Microchip’s...
Kensington, PQI Launch Synaptics-Enabled USB Fingerprint Dongles
Jan 05, 2017 13:02 pm UTC| Business
SAN JOSE, Calif. and LAS VEGAS, Jan. 05, 2017 -- CES--Synaptics Incorporated (NASDAQ:SYNA), the leading developer of human interface solutions, today announced its Natural ID™ fingerprint sensors are featured on new...
Jan 05, 2017 13:02 pm UTC| Business
NEW YORK, Jan. 05, 2017 -- ITG (NYSE:ITG), a leading independent broker and financial technology provider, today released a survey of North American institutional investors about the likely impacts of the Markets in...
VASCO to Announce Fourth Quarter and Fiscal Year 2016 Financial Results February 14, 2017
Jan 05, 2017 13:02 pm UTC| Business
OAKBROOK TERRACE, Ill. and ZURICH, Switzerland, Jan. 05, 2017 -- VASCO Data Security International, Inc. (NASDAQ:VDSI), a global leader in digital solutions including identity, security and business productivity,...
VASCO to Announce Fourth Quarter and Fiscal Year 2016 Financial Results February 14, 2017
Jan 05, 2017 13:02 pm UTC| Business
OAKBROOK TERRACE, Ill. and ZURICH, Switzerland, Jan. 05, 2017 -- VASCO Data Security International, Inc. (NASDAQ:VDSI), a global leader in digital solutions including identity, security and business productivity,...
VASCO to Announce Fourth Quarter and Fiscal Year 2016 Financial Results February 14, 2017
Jan 05, 2017 13:02 pm UTC| Business
OAKBROOK TERRACE, Ill. and ZURICH, Switzerland, Jan. 05, 2017 -- VASCO Data Security International, Inc. (NASDAQ:VDSI), a global leader in digital solutions including identity, security and business productivity,...
Cascadian Therapeutics Announces 2017 Outlook and Recent Drug Portfolio Progress
Jan 05, 2017 13:02 pm UTC| Business
SEATTLE, Jan. 05, 2017 -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced an overview of recent progress for its investigational drug portfolio in addition to...